Japan Tissue Engineering Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 15, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	27,330	24,204	18,559	27,737	21,158	20,833
Market Cap Growth	11.24%	30.42%	-33.09%	31.09%	1.56%	-32.05%
Enterprise Value	24,080	20,868	14,488	23,675	16,783	15,845
Last Close Price	673.00	596.00	457.00	683.00	521.00	513.00
PE Ratio	-	-	-	193.96	-	-
PS Ratio	12.53	11.09	7.56	11.03	10.41	9.91
PB Ratio	5.37	4.76	3.19	4.56	3.56	3.13
P/TBV Ratio	5.42	4.80	3.24	4.64	3.62	3.14
P/FCF Ratio	-	-	-	355.60	-	-
P/OCF Ratio	-	-	-	101.23	-	-
EV/Sales Ratio	11.04	9.56	5.90	9.42	8.26	7.53
EV/EBITDA Ratio	-	-	-	84.86	-	-
EV/EBIT Ratio	-	-	-	163.27	-	-
EV/FCF Ratio	-	-	-	303.52	-	-
Net Debt / Equity Ratio	-0.64	-0.64	-0.67	-0.70	-0.70	-0.74
Net Debt / EBITDA Ratio	8.27	8.27	48.56	-15.29	6.93	13.19
Net Debt / FCF Ratio	5.78	5.78	17.34	-54.69	5.36	15.04
Asset Turnover	0.36	0.36	0.36	0.36	0.28	0.27
Inventory Turnover	4.40	4.40	4.62	3.54	4.23	4.34
Quick Ratio	6.78	6.78	7.03	5.58	5.17	6.06
Current Ratio	7.47	7.47	7.57	6.12	5.72	6.64
Return on Equity (ROE)	-13.45%	-13.45%	-4.28%	2.38%	-11.57%	-7.19%
Return on Assets (ROA)	-5.64%	-5.64%	-2.20%	1.31%	-6.28%	-3.96%
Return on Invested Capital (ROIC)	-29.15%	-29.10%	-12.68%	7.85%	-41.18%	-27.50%
Return on Capital Employed (ROCE)	-10.70%	-10.70%	-4.10%	2.40%	-12.20%	-7.40%
Earnings Yield	-2.69%	-3.03%	-1.37%	0.52%	-3.45%	-2.39%
FCF Yield	-2.06%	-2.32%	-1.21%	0.28%	-3.64%	-1.57%